PARP inhibitors and their evolving role for the treatment of prostate cancer
PARP inhibitors and their evolving role for the treatment of prostate cancer
Disparities in access to oncology clinical trials across Europe
ALTA-1L: Brigatinib vs crizotinib for ALK advanced non small cell lung cancer patients
OncoAlert and ecancer weekly roundup for September 14-19, 2020
IMpassion130: Atezolizumab and nab-paclitaxel in triple-negative breast cancer
Osimertinib adjuvant therapy in patients with early stage EGFR mutated NSCLC after tumour resection
Estimate of the 2-year oncology workload generated by each new patient: A real-world study
OncoAlert and ecancer weekly roundup for September 6-13, 2020
OncoAlert and ecancer weekly roundup for August 30 - September 5 2020
Long radiotherapy waiting times in Nigeria
OncoAlert and ecancer weekly roundup for August 24-29 2020
Underutilisation of nuclear medicine scans at a regional hospital in Nigeria: need for implementation research